{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:59Z","timestamp":1761532319390,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.brachy.2023.08.001","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:36:08Z","timestamp":1694752568000},"page":"822-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5342-4128","authenticated-orcid":false,"given":"Jeremiah W.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat J.","family":"Kudchadker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aradhana M.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-5057","authenticated-orcid":false,"given":"Alexander N.","family":"Hanania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Thames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Starks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-7884","authenticated-orcid":false,"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.08.001_bib0001","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.brachy.2016.08.008","article-title":"Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer","volume":"15","author":"Ilg","year":"2016","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cncr.29743","article-title":"Utilizing time-driven activity based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer","volume":"122","author":"Laviana","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0003","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.26307","article-title":"Outcomes after prostate brachytherapy are even better than predicted","volume":"118","author":"Frank","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2023.08.001_bib0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2020.04.038","article-title":"A biochemical definition of cure after brachytherapy for prostate cancer","volume":"149","author":"Crook","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.01.005","article-title":"Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy","volume":"79","author":"Taira","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0006","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.brachy.2021.07.006","article-title":"Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement","volume":"20","author":"King","year":"2021","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0007","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.09.050","article-title":"Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes","volume":"100","author":"Frank","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0009","doi-asserted-by":"crossref","unstructured":"Fischer-Valuck B, Gay HA, Patel S, et al. A brief review of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy boost for high-risk prostate. Front Oncol. 2019;9:1378.","DOI":"10.3389\/fonc.2019.01378"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.06.020","article-title":"Brachytherapy boost utilization and survival in unfavorable-risk prostate cancer","volume":"72","author":"Johnson","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.21037\/tau.2017.12.15","article-title":"Low dose rate prostate brachytherapy","volume":"7","author":"Stish","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.brachy.2023.08.001_bib0013","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0302-2838(02)00018-0","article-title":"Importance of post-implant dosimetry in permanent prostate brachytherapy","volume":"41","author":"Stock","year":"2002","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.brachy.2023.08.001_bib0014","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.urology.2003.07.004","article-title":"Importance of implant dosimetry for patients undergoing prostate brachytherapy","volume":"62","author":"Potters","year":"2003","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1538-4721(02)00014-4","article-title":"Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy","volume":"1","author":"Crook","year":"2002","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0360-3016(02)02950-4","article-title":"Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy","volume":"54","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.radonc.2021.12.011","article-title":"Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry","volume":"169","author":"Sanders","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.08.001_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.radonc.2021.12.033","article-title":"Computer-aided segmentation on MRI for prostate radiotherapy, Part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability","volume":"169","author":"Sanders","year":"2022","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0019","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijrobp.2020.09.040","article-title":"Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study","volume":"109","author":"Sanders","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ijrobp.2020.06.076","article-title":"Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy","volume":"108","author":"Sanders","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.brachy.2023.08.001_bib0021","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1002\/mrm.27677","article-title":"Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS)","volume":"81","author":"Sanders","year":"2019","journal-title":"Magn Reson Med"},{"issue":"7","key":"10.1016\/j.brachy.2023.08.001_bib0022","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1109\/TMI.2004.828354","article-title":"Simultaneous truth and performance level estimation (STAPLE): An algorithm for the validation of image segmentation","volume":"23","author":"Warfield","year":"2004","journal-title":"IEEE Trans Med Imaging"},{"issue":"1","key":"10.1016\/j.brachy.2023.08.001_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0024","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0360-3016(01)01473-0","article-title":"A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy","volume":"50","author":"Potters","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0360-3016(03)01448-2","article-title":"125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial","volume":"57","author":"Wallner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brachy.2013.08.006","article-title":"Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive 125I monotherapy patients","volume":"13","author":"Morris","year":"2014","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0028","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2008.07.042","article-title":"Evaluation of dosimetric parameters and disease response after 125Iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer","volume":"73","author":"Morris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1095","key":"10.1016\/j.brachy.2023.08.001_bib0029","article-title":"Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy","volume":"92","author":"Pathmanathan","year":"2019","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.brachy.2023.08.001_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jrr\/rrz012","article-title":"Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging\/computed tomography fusion image\u2013based post-implant dosimetry of prostate brachytherapy","volume":"60","author":"Kenta","year":"2019","journal-title":"J Radiat Res"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0031","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jmrs.168","article-title":"Maintaining prostate contouring consistency following an educational intervention","volume":"63","author":"Nicholls","year":"2016","journal-title":"J Med Radiat Sci"},{"issue":"4","key":"10.1016\/j.brachy.2023.08.001_bib0032","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ijrobp.2006.11.027","article-title":"Prostate volume contouring: A 3D analysis of segmentation using 3D TRUS, CT, and MR","volume":"67","author":"Smith","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0033","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.ijrobp.2011.02.050","article-title":"Prostate contouring variation: Can it be fixed?","volume":"82","author":"Khoo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0034","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0035","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.ijrobp.2011.01.012","article-title":"Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: Rectal dose-volume histogram analysis of 457 patients","volume":"81","author":"Shiraishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0036","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00130404-200509000-00005","article-title":"I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial","volume":"11","author":"Herstein","year":"2005","journal-title":"Cancer J"},{"issue":"5","key":"10.1016\/j.brachy.2023.08.001_bib0037","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2013.04.033","article-title":"Predictive factors and management of rectal bleeding side effects following prostate cancer brachytherapy","volume":"86","author":"Price","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2023.08.001_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijrobp.2015.05.014","article-title":"Urinary and rectal toxicity profiles after permanent iodine-125 implant brachytherapy in Japanese men: Nationwide J-POPS multi-institutional prospective cohort study","volume":"93","author":"Ohashi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0039","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2020.12.004","article-title":"Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study","volume":"20","author":"Sakurai","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.001_bib0040","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brachy.2020.06.011","article-title":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","volume":"19","author":"Boyce-Fappiano","year":"2020","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2023.08.001_bib0041","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2012.06.014","article-title":"Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion","volume":"104","author":"De Brabandere","year":"2012","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.brachy.2023.08.001_bib0042","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.brachy.2013.06.003","article-title":"CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy","volume":"12","author":"De Brabandere","year":"2013","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2023.08.001_bib0043","first-page":"105","article-title":"Inter-observer variability in post-plan seed localization after permanent prostate brachytherapy: A multicentric study","volume":"20","author":"Orlandini","year":"2004","journal-title":"Phys Med"},{"key":"10.1016\/j.brachy.2023.08.001_bib0044","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-8140(01)00475-3","article-title":"Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry","volume":"62","author":"Al-Qaisieh","year":"2002","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.brachy.2023.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1118\/1.1576232","article-title":"The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters","volume":"30","author":"Han","year":"2003","journal-title":"Med Phys"},{"issue":"7","key":"10.1016\/j.brachy.2023.08.001_bib0046","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1118\/1.1586451","article-title":"A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation","volume":"30","author":"Lindsay","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.08.001_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.02.040","article-title":"Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy","volume":"159","author":"Cha","year":"2021","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:19:30Z","timestamp":1761531570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123016148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1538472123016148"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}